Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![baro_jwngma Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1120936414743416832.png) Hello Market [@baro_jwngma](/creator/twitter/baro_jwngma) on x XXX followers
Created: 2025-07-15 06:44:39 UTC

MSN Laboratories wins patent litigation for Novartis drug Entresto, potentially impacting Divis Laboratories' revenue by up to $XXX million annually.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945011612957503871/c:line.svg)

**Related Topics**
[$divislabbo](/topic/$divislabbo)
[novartis](/topic/novartis)
[$novnsw](/topic/$novnsw)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/baro_jwngma/status/1945011612957503871)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

baro_jwngma Avatar Hello Market @baro_jwngma on x XXX followers Created: 2025-07-15 06:44:39 UTC

MSN Laboratories wins patent litigation for Novartis drug Entresto, potentially impacting Divis Laboratories' revenue by up to $XXX million annually.

XX engagements

Engagements Line Chart

Related Topics $divislabbo novartis $novnsw stocks healthcare

Post Link

post/tweet::1945011612957503871
/post/tweet::1945011612957503871